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Changes of plasma l ip id levels present one of the most essential coronary 
r i sk factors after hypertension and smoking. Some authors (11) note that the 
appearance of a myocardial infarction can be predicted by means of the analy­
sis of the fatty-acid composition of serum l ipids . 
Beta adrenergic blockers which have occupied stable positions in antihy­
pertensive therapy as wel l as in the treatment of the coronary disease and some 
arrhythmias could not demonstrate a definite preventive effect on ischemic 
accidents probably because of unfavourable metabolic effects especially con­
cerning plasma lipids (10). A series of investigations revealed that both non- . 
selective and selective (not rare ly) beta blockers induced plasma triglyceride 
level increase (5 , 14, 15) and reduced HDL-cholesterol level and H D L - c t n l e -
sterol: L D L cholesterol ratio (8, 10, 15). I t is found out that there is an antago­
nist ic action upon isoprenaline-induced increase of plasma free fatty acids ( F F A ) 
in healthy volunteers (7) as we l l as an i n i t i a l serum F F A reduction after prolong­
ed betk blocker application (9 ) . There are scanty data about beta blocker in­
fluence upon tissue or plasfria ind iv idua l F F A levels (12). 
The oblect of the present communication are the first results from our in­
vestigation of the influence of propranolol, the rnost-widely used non-selective 
beta blocker, on l ip id metabolism. Both dose- and time-dependences of propra­
nolol action on serum levels of eight individual F F A in white male rats are studied 
Material and methods 
The study covered 72 white male rats wi th b. w. of 150.0 — 170Л g. Pro­
pranolol was in t raper i tonea l^ applied, at doses of 1 mg, 3 mg and 9 mg/kg b. w. 
A n i m a l s were k i l l ed by cut t ing of the sub l ingua l veins on the 1 s t , 2 n d and 4 t h 
hour after drug administration. Control animals injected w i t h saline were also 
k i l l ed for corresponding dosages and intervals of drug injections. Sertim was 
extracted after Folsh 's et a l . method (1957). L i p i d fractioning was performed by 
means of thih- layer chromatography in the system of hekane: aether: acetic 
ac id ( ra t io 35 : 15 : 1) ( I ) . F F A s were fluorescently v isual ized in u l t rav io le t 
l ight and quant i t a t ive ly isolated. Then they were methylated wi th diazome-
thane a'nd gas-chromatographically analyzed. The method was adapted on Chrom-
4 apparatus w i t h phase D E D S and chromosorb — W car r ie r , wi th flame-ioni-
zation detector. Quant i t ies of single F F A : myr is t ic acid ( C u : 0) . pa lmi t ic ac id 
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1 6 : 0) , pa lmi to l e i cac id (C I 6 : I ) , stearic acid.(C, 8 : 0) ; oleic acid ( 1 8 : 1), l inol ic 
acid ( C 1 8 : 2 ) , eicosantrienic acid ( С э : 3 ) , and araehidonie acid (20 : 4 ) : were 
calculated on the basis of intrinsic standard as arachidic acid ( C 4 0 : 0) added 
Ao the serum prior to ext rac t ion . 
IGUrS 
Results and distussion 
Our results obtained demonstrated a linear dose- and time-dependent re­
duction of total F F A concentrations (fig. 1). A t dose of 9 mg/kg b. w. , total F F A s 
decrease l inear ly during the period from the first to the fourth hour after injec­
t ion. On the 4 t h hour, this 
reduction is by 43.4 per 
cent and stat is t ical ly signi­
ficant in comparison wi th 
that of the control val i ies . 
However, at dose of 3 mg-
kg b. w . , reduction is by 
20.3 per cent only. 
Quant i ta t ively , indi­
vidual F F A decrease is dif­
ferently expressed. I t va ­
ries between 17.5 per cent 
(for C i 6 : 1) and 57.3 per 
cent (for C i 8 : 2) at propra­
nolol dose of 9 mg/kg b. w. 
and 4-hour in terval . Reduc­
tion of concentration^ of 
the most important acids 
in F F A pool, namely C 1 6 : 0 
and C 1 8 : 1, is close to the 
decrease of total F F A s — 
by 38.5 and 45.1 percent , 
respectively (p < 0.001) 
(fig. 2 ) . S i m i l a r l y to the 
case of total F F A s , propra­
nolol effect on the levels of 
these two F F A s demonstra­
tes a l inear t ime-and dose-
dependence. C 1 8 :2 submits 
to the same dependence, 
too (fig. 2). I ts max ima l 
reduction is by 57.3 per 
cent at doses of 9 mg/kg b, 
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Fig. 
acid 
J . a . T ime-dependent changes of se rum free fa t ty 
concent ra t ions after s ing le i . p. propranolol app­
l i c a t i o n (at dosis of 9 mgk/g) i n r a t s . 
F i g . 1. — b. Dose-dependent changes of serum free fa t ty 
ac id concent ra t ionsa * after s ingle i . p. propranolol 
a p p l i c a t i o n (4 hours after in jec t ion) i n ra t s . 
p.00 ) . C U : OandQe : Oboth show a linear dose-dependence (fig. 3) . The rest three 
d F A s : C 1 8 : 1 , C 2 0 : 4, and C , 0 : 3 do not s t r ic t ly submit to these dependences. Araeh i ­
donie acid increases at the" lowest propranolol dose used (fig. 4 ) . Th i s result is r a -
her interesting on the background of total F F A reduction and it cannot be explain-
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ed by propranolol blockade of beta-adrenoceptors. Besides as it is well-known, 
propranolol is deprived of intr insic sympathicomlmetic ac t iv i ty . A t doses of 
3 mg and 9 mg/kg b. w. of the beta blocker, araehidonie acid levels decrease 
(fig. 4 ) , s ta t i s t ica l ly s ignif icant ly at dose of 9 mg/kg b. w. (p < 0.01). 
F i g . 2 . Legend : 
о P a l m i t i c ac id 
x O l e i c ac id 
О L i n o l e i c ac id 
F i g . 2 -a . Time-dependent changes of serum concentra t ions of p a l m i t i c , o le ic and l ino le ic acids 
after s ing le i . p . propranolol a p p l i c a t i o n i n ra ts , (a t dosis of 9 mg/kg) 
F i g . . 2-b. Dose-dependent changes of se rum concentra t ions of p a l m i t i c , oleic and l i n o l e i c 
acids after s ing le i . p. propranolol a p p l i c a t i o n (4 hours after in jec t ion) in r a t s . 
T h i s reduction of total F F A s influenced by propranolol is in concordance 
wi th F F A decrease reported by other authors concerning the appl icat ion of 
the ssfme beta-blocker in dogs (2) and humans (3 , 9, 13). Only the communication 
of T a n a k a et a l . ( i976) about F F A level increase after propranolol administra­
tion is aSn exception i n this case. 
Dhese data show that propranolol induces quant i ta t ive ly differently ma­
nifested and in cer ta in cases e«yen oppositely directed (e. g. wi th C , 0 : 4) changes 
in i nd iv idua l serum F F A levels under the condition of our t r i a l . I t a l lows us 
to assume that beta-adrenergic control of l ipolysis is of different importance 
for single F F A s . 
The significant decrease of l inoleic acid ( C , 8 : 2) concentration seems to be 
part icular ly important when character izing propranolol action because it is 
established that this acid reduces in p lasma cholesterol esters of patients w i t h 
ischemic heart disease and myocard ia l infarct ion (11). 
The changes of serum araehidonie ac id levels revealed in our study pre­
sent a certain interest, too. Miura et a l . (1988) report that under ischemic con­
ditions of the myocardium in dogs on the background of total moderate F F A 
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x M v i i s t i c ac id о Stear ic acid 
mi 3-a . Time-dependent changes of se rum concentra t ions of m y r i s t i c and s tea r ic acids after 
tie i. p. propranolol a p p l i c a t i o n (a t dosis 9 mg/kg) i n r a t s , 
i g . . 3-b. Dose-dependent changes of s e r u m concent ra t ions of m y r i s t i c and s tea r ic acids af-
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F i g . 4 -a . Time-dependent changes of se rum concent ra t ion of a r ach idon ic a c i d after s ing le 
. i . p . propranolol a p p l i c a t i o n (at dosis of 9 mg/kg) i n ra t s . 
F i g . 4-b. Dose-dependent changes of s e rum concent ra t ion of a r ach idon i c ac id after s ing le 
i . p. propranolol a p p l i c a t i o n (4 hours after in jec t ion) i n r a t s . 
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concentration increase in the myocardium araichidonic a c i d level increases al­
most threefold and more and that this increase disappear almost completely 
after propranolol treatment. However, in spite of the suggestions that this ac­
t ion of the beta blocker is related to restoration of reduced myocardia l A T P 
content necessary for the real izat ion of processes of phospholipid reacidulation 
(4. 12) the exact mechanism of propranolol i nh ib i t o ry action on ischemia-in­
duced F F A accumulation remains unc la r i f ied yet. 
The undoubted part ic ipat ion of F F A exchange and especial ly of polyenic 
F F A one at the pathogenesis of ischemic myocardial conditions as wel l as pro­
pranolol influence upon this exchange provides a serious reason for further 
enlargement of the investigations of the action of beta blockers being a separate 
medic ina l group on this aspect of l i p i d mtabol ism. D y n a m i c and in detail 
follow-up of the changes of total and i n d i v i d u a l F F A levels could be of most 
essential importance When patients w i th disturbed l i p id metabolism on beta 
blocker treatment are concerned. 
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Р Е З Ю М Е 
И с с л е д о в а н о в л и я н и е п р о п р а н о л о л а на в о с е м ь с в о б о д н ы х ж и р н ы х к и с л о т у б е л ы х к р ы с 
с а м ц о в на с ы в о р о т о ч н о м у р о в н е . С в о б о д н ы е ж и р н ы е к и с л о т ы и с с л е д о в а л и с ь з а 1 , 2 и 4 часа 
д о в в е д е н и я п р о п р а н о л о л а и с т о л ь к о ж е ч а с о в п о с л е е го в в е д е н и я . П р о п р а н о л о л в в о д и л с я 
в д о з а х 1, 2 и 3 м г / к г с и з п о л ь з о в а н и е м г а з ж и д к о й х р о м а т о г р и ф и и . У с т а н о в л е н о у м е н ь ш е 
н и е к о н ц е н т р а ц и и т о т а л ь н ы х с в о б о д н ы х ж и р н ы х к и с л о т в з а в и с и м о с т и от в р е м е н и и д о з . 
Э т а з а в и с и м о с т ь л и н е й н о г о х а р а к т е р а . З а в и с и м о с т и от д о з ы и в р е м е н и в ы з ы в а ю т к о л и ч е ­
с т в е н н о р а з л и ч н ы е и з м е н е н и я у р о в н я и н д и в и д у а л ь н ы х с в о б о д н ы х ж и р н ы х к и с л о т . 
О б с у ж д а е т с я р а з л и ч н о е з н а ч е н и е а д р э н е р г и ч е с к о г о к о н т р о л я л н л о л и з а д л я о т д е л ь н ы х 
с в о б о д н ы х ж и р н ы х к и с л о т . 
